RTC-5
RTC-5 (TRC-382) is an optimized phenothiazine with anti-cancer potency. RTC-5 demonstrates efficacy against a xenograft model of an EGFR driven cancer, its effects is attributed to concomitant negative regulation of PI3K-AKT and RAS-ERK signaling[1].
Product Specifications
CAS Number
1423077-49-9
Product Name Alternative
TRC-382
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rtc-5.html
Concentration
10mM
Purity
99.37
Solubility
DMSO : 15 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(OC(F)(F)F)C=C1)(NCCCN2C3=CC(Cl)=CC=C3CCC4=CC=CC=C42)=O
Molecular Formula
C24H22ClF3N2O3S
Molecular Weight
510.96
References & Citations
[1]Kastrinsky DB, et al. Reengineered tricyclic anti-cancer agents. Bioorg Med Chem. 2015 Oct 1;23 (19) :6528-34.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Biotin-Linked Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 1 (CXCL1)
Biotin-Linked Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 1 (CXCL1)
